Intas develops COVID-19 Hyperimmune Globulin, gets human trial approval
Intas Pharmaceuticals Ltd., the largest supplier by volume of generic medicines to the UK NHS, is collaborating on a World Health Organisation endorsed study into the prevention of COVID-19 infection using hydroxychloroquine, a drug that may have an effect in preventing and/or reducing symptoms of COVID-19.
▶︎
From Poison to Cure: The $13 Billion Medicine Revolution
▶︎
Aaj Ki Baat | Rajat Sharma: चंपत राय के जाने का क्या असर होगा? | Ram Mandir | Champat Rai | Congress
▶︎
Billionaire’s Brain vs Your Brain: Morning Routine, Focus & Addiction | Dr Sweta | FO403 Raj Shamani
▶︎
News Ki Pathshala With Rubika Liyaquat : PM Modi के इंडोनिशिया दौरे से क्यों बढ़ी हलचल ? Top News
▶︎
Gold's Biggest Fall Since 2008 Explained | Vantage LIVE
▶︎
Doctor reveals undisclosed risks of COVID-19 vaccine
▶︎
'CANCER OCCURRED near injection sites...': Bombshell testimony ‘EXPOSES’ COVID-19 vaccine injuries
▶︎
Learn RAG From Scratch – Python AI Tutorial from a LangChain Engineer
▶︎
What if a blood-sucking tick ends up in an antlion's den?
▶︎
Aaj Ki Baat Show के आज के Highlights | 06 July 2026 | Ram Mandir Donation | Punjab Congress | Bengal
▶︎
Gold's Biggest Fall Since 2008 Explained | Vantage LIVE
▶︎
Sarah Paine — The war for India (Lecture & interview)
▶︎
Desh Ki Pathshala With Sushant Sinha | देश की पाठशाला Episode 19 | Ram Mandir | Champat Rai
▶︎
Anti-Aging Expert: This Reverses Gray Hair, Fixes Health & Prevents Cancer!
▶︎
News Ki Pathshala | Rubika Liyaquat | PM Modi Indonesia Visit | क्या चीन-पाकिस्तान की बढ़ी टेंशन?
▶︎
India vs Pakistan Over Indus Waters Treaty: 'Water War' Coming Soon? | Tilak & Uttam | EP429
▶︎
Jobs At Risk, The AI Boom Or Bubble Debate & Stock Market Valuations: Aswath Damodaran's Interview
▶︎
The Anticancer Potential of Ivermectin and Fenbendazole
▶︎
News Ki Pathshala | Rubika Liyaquat: इंडोनेशिया में पीएम मोदी का खास स्वागत..हुआ रामायण का आयोजन !
▶︎